Illumina is committed to delivering cutting-edge clinical cancer sequencing solutions to drive discoveries in oncology.
Meet with us at the 2018 American Society of Clinical Oncology (ASCO) annual meeting to discuss emerging trends in clinical cancer research:
Learn how you can apply genomic innovations to find the valuable insights you need.
Stop by booth 2124 to meet with us.
Illumina next-generation sequencing (NGS) technology helps you generate accurate reference genomes for microbial identification and other comparative genomic studies.
Visit us at ASM booth 2501 to learn how our comprehensive microbiology solutions enable targeted sequencing and shotgun metagenomics. See our new iSeq 100 Sequencing System, which is making NGS easier and more affordable than ever.
Visit us at stand 540 to learn about our latest advancements in genomic solutions. From whole-genome sequencing to single cell sequencing, we have solutions across the genomic spectrum. Attend our presentations, product demonstrations, and social event to find out more.
Visit us at stand 31 & 32 to learn about our latest advancements
in genomic solutions for Cancer Research. Attend our workshop on
Monday 02 July in room G105 to learn how: “How can next-generation
sequencing (NGS) can empower your next cancer research
The session will feature two presentations: one discussing how single cell genomics is transforming our understanding of various immune-related pathologies, such as cancer and one about how RNA-Seq can provide insights into quantification of immune contexture within human tumors.
Visit Illumina on booth #5 at ISPD 2018 in Antwerp.
Illumina is the leading technology provider for noninvasive prenatal
testing (NIPT), enabling health care professionals and expectant
parents to be informed about their pregnancy. Illumina is dedicated to
improving health through genomics.